Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D G Zarembski

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|February 1, 1997
Mycophenolate mofetil: a unique immunosuppressive agentK A Hood, D G Zarembski
The American Journal of Cardiology|June 1, 1996
Meta-analysis of the use of low-dose beta-adrenergic blocking therapy in idiopathic or ischemic dilated cardiomyopathyD G Zarembski, P E Nolan, M K Slack, et al.
Archives of Internal Medicine|December 13, 1993
Empiric long-term amiodarone prophylaxis following myocardial infarction. A meta-analysisD G Zarembski, P E Nolan, M K Slack, et al.
Archives of Internal Medicine|September 25, 1995
Treatment of resistant atrial fibrillation. A meta-analysis comparing amiodarone and flecainideD G Zarembski, P E Nolan, M K Slack, et al.
Pharmacotherapy|February 25, 1999
Impact of rifampin on serum amiodarone concentrations in a patient with congenital heart diseaseD G Zarembski, S A Fischer, P A Santucci, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|February 1, 1997
Mycophenolate mofetil: a unique immunosuppressive agentK A Hood, D G Zarembski
The American Journal of Cardiology|June 1, 1996
Meta-analysis of the use of low-dose beta-adrenergic blocking therapy in idiopathic or ischemic dilated cardiomyopathyD G Zarembski, P E Nolan, M K Slack, et al.
Archives of Internal Medicine|December 13, 1993
Empiric long-term amiodarone prophylaxis following myocardial infarction. A meta-analysisD G Zarembski, P E Nolan, M K Slack, et al.
Archives of Internal Medicine|September 25, 1995
Treatment of resistant atrial fibrillation. A meta-analysis comparing amiodarone and flecainideD G Zarembski, P E Nolan, M K Slack, et al.
Pharmacotherapy|February 25, 1999
Impact of rifampin on serum amiodarone concentrations in a patient with congenital heart diseaseD G Zarembski, S A Fischer, P A Santucci, et al.
Pageof 1